Glaukos Corporation (GKOS) Tops Q1 EPS by 18c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Glaukos Corporation Announces First Quarter 2016 Financial Results
May 3, 2016 4:15 PM EDTCompany Raises 2016 Net Sales Guidance
LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the first quarter ended March 31, 2016. Key highlights include:
Achieved 57% net sales growth to $23.1 million in the first quarter of 2016, compared to $14.7 million in the first quarter of 2015 Expanded gross margin to 86% in the first quarter of 2016, compared to 81% in the first... More